It has also been shown that MEK and BRAF inhibitors can increase the number of macrophages, as well as their expression of tumor necrosis factor-α (TNF-α), mediating upregulation of MITF expression in melanoma cells through NF-κB activation. This evidence concerns the gene BRAF and melanoma.